Loading organizations...
§ Private Profile · Tel Aviv, Israel
Remilk is a technology company.
Remilk develops and produces animal-free dairy ingredients, offering a sustainable alternative to traditional milk proteins. The company leverages precision fermentation technology, utilizing microbes to cultivate identical dairy proteins that can be incorporated into a variety of food products, effectively replicating the taste, texture, and nutritional value of conventional dairy without requiring cows. This approach provides a consistent and scalable supply of dairy components.
The company was founded in 2019 by Aviv Wolff, who serves as CEO, and Ori Cohavi, a biochemist. Their collaboration stemmed from a shared vision to create genuine dairy products that avoid the environmental and ethical concerns associated with industrial animal agriculture, focusing instead on a more sustainable and efficient production method. This insight aimed to decouple dairy production from animal sourcing.
Remilk's products are designed for food manufacturers seeking to offer dairy items that align with evolving consumer preferences for animal-free and environmentally conscious options. The company's overarching vision is to reshape the future of food by providing healthy, planet-friendly, and delicious dairy ingredients, contributing to a more sustainable and ethical global food system.
Remilk has raised $131.0M across 2 funding rounds.
Remilk has raised $131.0M in total across 2 funding rounds.
Remilk has raised $131.0M in total across 2 funding rounds.
Remilk's investors include Hanaco Ventures, Left Lane Capital, Gil Ofer, Idan Ofer, Aliya Capital Partners, Chartered Group, CPT Capital, Fresh Fund, Indorama Ventures, Intercap, Izaki Ventures, OurCrowd.
Remilk has raised $131.0M across 2 funding rounds. Most recently, it raised $120.0M Series B in January 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 1, 2022 | $120M Series B | Hanaco Ventures | Left Lane Capital, GIL Ofer, Idan Ofer, Aliya Capital Partners, Chartered Group, CPT Capital, Fresh Fund, Indorama Ventures, Intercap, Izaki Ventures, OurCrowd, Paradigm Shift Fund, Precision Capital, Rage Capital, TAL Ventures | Announced |
| Dec 1, 2020 | $11M Series A | Fresh.fund | Hummingbird Ventures, Prime Ventures, Amiad Solomon, Beni Nofech, Bradley Bloom, Sake Bosch, CPT Capital, Hochland, OurCrowd, ProVeg International, Tempo, Tnuva | Announced |
Remilk is an Israeli biotechnology company founded in 2019 that produces animal-free dairy proteins using precision fermentation, enabling real dairy products like milk, cheese, yogurt, and ice cream without cows.[1][4][5] It serves food manufacturers and major brands such as General Mills and Gad Dairies, solving the environmental and ethical challenges of traditional dairy production by creating chemically identical proteins that use 1% of the land, 5% of the water, and emit 4-97% fewer greenhouse gases while eliminating lactose, cholesterol, hormones, and antibiotics.[1][2][6] Remilk has raised over $150 million, secured regulatory approvals in the US, Israel, Canada, and Singapore, launched products like cow-free cream cheese and "The New Milk" in markets including the US and Israel, and is building the world's largest precision fermentation facility in Denmark to scale production.[1][2][5]
Remilk was founded in 2019 in Israel by CEO Aviv Wolff and CTO Dr. Ori Cohavi, a biochemist, with the goal of decoupling dairy production from livestock while preserving taste, texture, and nutrition.[4][5][6] The idea emerged from copying cow milk protein genes (casein and whey) into yeast cells, turning them into efficient "protein factories" via precision fermentation—a modern twist on ancient fermentation methods.[5][6][8] Early traction included raising over $150 million in funding, developing patented scalable manufacturing, achieving FDA Self Affirmed GRAS status, and partnering with giants like General Mills for animal-free cheese and Gad Dairies for Israel's first cow-free milk launch in 2024, marking pivotal commercialization steps.[2][3][5]
Remilk rides the precision fermentation wave in alternative proteins, projected to capture 11% ($290B) of the global protein market by 2035 amid rising demand for sustainable food tech.[1] Timing aligns with climate pressures on dairy—responsible for significant emissions and resource use—fueled by regulatory pushes for net-zero (e.g., UN 2050 goals) and consumer shifts toward ethical, low-impact products.[1][6] Market forces like partnerships with incumbents (General Mills, Gad) accelerate adoption, bypassing plant-based limitations by offering "real dairy" that integrates seamlessly into existing supply chains.[2][3] Remilk influences the ecosystem by proving animal-free dairy at scale, inspiring competitors, and normalizing biotech in food, potentially disrupting the $800B+ dairy industry.[1][5]
Remilk is poised for explosive growth with its Denmark mega-facility enabling global supply, expanding partnerships, and new product categories beyond cream cheese and milk.[1][2] Trends like tightening emissions regulations, precision fermentation advancements, and alternative protein mainstreaming will propel it, potentially capturing significant dairy market share as costs align with traditional methods.[1][2] Its influence may evolve from innovator to infrastructure provider, reshaping dairy toward sustainability while maintaining the "real deal" appeal that hooked consumers from day one.[7]